S100A9 and neurodegenerative disease: We provided a detailed characterisation of our cohort, including an analysis of biomarkers such as NfL, S100A9, kynurenic acid (KYNA), and GAD1, all of which are well documented in the literature for their importance in neurodegenerative diseases [13,14,15].